Publications by authors named "Katherine Janeway"

93Publications

Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysis.

Pediatr Blood Cancer 2020 Nov 30:e28834. Epub 2020 Nov 30.

Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.28834DOI Listing
November 2020

Safety and efficacy of gamma-secretase inhibitor nirogacestat (PF-03084014) in desmoid tumor: Report of four pediatric/young adult cases.

Pediatr Blood Cancer 2020 Aug 6:e28636. Epub 2020 Aug 6.

Division of Hematology/Oncology, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.28636DOI Listing
August 2020

Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers.

Clin Cancer Res 2020 Jun 2;26(12):2882-2890. Epub 2020 Mar 2.

Department of Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-3089DOI Listing
June 2020

PD-1 and PD-L1 Expression in Osteosarcoma: Which Specimen to Evaluate?

J Pediatr Hematol Oncol 2020 Nov;42(8):482-487

Department of Pathology, Boston Children's Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000001685DOI Listing
November 2020

Pediatric Trials for Cancer Therapies With Targets Potentially Relevant to Pediatric Cancers.

J Natl Cancer Inst 2020 03;112(3):224-228

Pediatric Therapeutics and Regulatory Science Initiative, Computational Health Informatics Program, Boston Children's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djz207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073929PMC
March 2020

Ushering in the next generation of precision trials for pediatric cancer.

Science 2019 Mar;363(6432):1175-1181

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aaw4153DOI Listing
March 2019

A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group.

Pediatr Blood Cancer 2019 02 30;66(2):e27524. Epub 2018 Oct 30.

Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27524DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501793PMC
February 2019

Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group.

Pediatr Blood Cancer 2019 01 25;66(1):e27444. Epub 2018 Sep 25.

Center for Cancer and Blood Disorders, Connecticut Children's Medical Center, Hartford, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249072PMC
January 2019

Dose Intensification Improves the Outcome of Ewing Sarcoma.

J Clin Oncol 2018 Sep 12:JCO2018793489. Epub 2018 Sep 12.

Richard Gorlick, The University of Texas MD Anderson Cancer Center, Houston, TX; Katherine A. Janeway, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA; and Peter C. Adamson, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Philadelphia, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.79.3489DOI Listing
September 2018

Precision medicine in pediatric oncology.

Curr Opin Pediatr 2018 02;30(1):17-24

Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOP.0000000000000570DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770114PMC
February 2018

Advances in the Treatment of Pediatric Bone Sarcomas.

Am Soc Clin Oncol Educ Book 2017 ;37:725-735

From the Van Andel Research Institute/Helen DeVos Children's Hospital, Grand Rapids, MI; Harvard Medical School, Boston, MA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA; Department of Pediatrics and Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066791PMC
November 2017

Pediatric oncology enters an era of precision medicine.

Curr Probl Cancer 2017 May - Jun;41(3):194-200. Epub 2017 Feb 1.

Department of Pediatrics, Baylor College of Medicine, Houston, Texas; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.currproblcancer.2017.01.002DOI Listing
March 2018

Molecular profiling in the clinic: Moving from feasibility assessment to evaluating clinical impact.

Pediatr Blood Cancer 2017 06 24;64(6). Epub 2017 Feb 24.

Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26482DOI Listing
June 2017

Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors.

Neuro Oncol 2017 Jul;19(7):986-996

Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Department of Pathology, Department of Radiology, Department of Neurosurgery, Boston Children's Hospital, Boston, Massachusetts; Department of Medical Oncology, Oncologic Pathology, Department of Pediatric Oncology, Department of Cancer Biology, Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Pathology, Department of Neurosurgery, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Pratiti Bandopadhayay, Broad Institute of MIT and Harvard, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570190PMC
July 2017

Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic.

J Clin Oncol 2017 Feb 28;35(5):523-528. Epub 2016 Dec 28.

Christopher B. Weldon and Arin L. Madenci, Boston Children's Hospital; Christopher B. Weldon, Arin L. Madenci, Katherine A. Janeway, and Suzanne George, Harvard Medical School; Christopher B. Weldon, Katherine A. Janeway, and Suzanne George, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Arin L. Madenci, Brigham and Women's Hospital, Boston, MA; Sosipatros A. Boikos, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA; Margaret von Mehren, Fox Chase Cancer Center, Philadelphia, PA; Alberto S. Pappo, St Jude Children's Research Hospital, Memphis, TN; Joshua D. Schiffman and Jennifer Wright, Huntsman Cancer Institute, Salt Lake City, UT; Jonathan C. Trent, Sylvester Comprehensive Cancer Center, Miami, FL; Karel Pacak and Constantine A. Stratakis, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Lee J. Helman, National Cancer Institute, Bethesda, MD; and Michael P. La Quaglia, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.6733DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455315PMC
February 2017

Liposomal doxorubicin: Effective treatment for pediatric desmoid fibromatosis.

Pediatr Blood Cancer 2017 Jul 1;64(7). Epub 2016 Dec 1.

Department of Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26375DOI Listing
July 2017

The case for informative phase 2 trials in osteosarcoma.

Lancet Oncol 2016 08;17(8):1022-1023

The Children's Hospital of Montefiore, Bronx, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30293-5DOI Listing
August 2016

Pediatric Oncology Provider Views on Performing a Biopsy of Solid Tumors in Children with Relapsed or Refractory Disease for the Purpose of Genomic Profiling.

Ann Surg Oncol 2016 12 26;23(Suppl 5):990-997. Epub 2016 Jul 26.

Division of Pediatric Hematology/Oncology and Blood & Marrow Cell Transplantation, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-016-5453-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611840PMC
December 2016

Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma.

F1000Res 2016 6;5. Epub 2016 Jul 6.

Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.8228.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937817PMC
July 2016

Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience.

Pediatr Blood Cancer 2016 11 18;63(11):1974-82. Epub 2016 Jul 18.

Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26137DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611837PMC
November 2016

Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward.

J Clin Oncol 2016 09 11;34(25):3031-8. Epub 2016 Jul 11.

Joanne P. Lagmay, Shands Hospital for Children, University of Florida, Gainesville, FL; Mark D. Krailo and Ha Dang, University of Southern California, Los Angeles; and Children's Oncology Group, Monrovia; Theodore Zwerdling, Jonathan Jaques Children's Cancer Center, Miller Children's and Women's Hospital, Long Beach, CA; AeRang Kim, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC; Douglas S. Hawkins, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA; Orren Beaty III, Zeiss Children's Cancer Center, Mission Hospitals, Asheville, NC; Brigitte C. Widemann, National Institutes of Health Clinical Center, Bethesda, MD; Lisa Bomgaars and Susan M. Blaney, Baylor College of Medicine/Texas Children's Cancer Center, Houston; Anne-Marie Langevin, University of Texas Health Science Center at San Antonio, San Antonio, TX; Holcombe E. Grier and Katherine A. Janeway, Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center, Boston, MA; Brenda Weigel, University of Minnesota, Minneapolis, MN; and Richard Gorlick, The Albert Einstein College of Medicine of Yeshiva University, The Children's Hospital at Montefiore, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.5381DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012712PMC
September 2016

Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcoma.

Cold Spring Harb Mol Case Stud 2015 Oct;1(1):a000471

Columbia University Medical Center, Department of Pediatric Oncology/Hematology/Stem Cell Transplantation, Department of Pediatrics, New York, New York 10032, USA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a000471DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850889PMC
October 2015

Future directions in the treatment of osteosarcoma.

Curr Opin Pediatr 2016 Feb;28(1):26-33

aDepartment of Oncology, St. Jude Children's Research Hospital bDepartment of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee cDana-Farber Cancer Institute, Boston, Massachusetts dDivision of Pediatric Hematology/Oncology, The Children's Hospital At Montefiore, Bronx, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOP.0000000000000298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761449PMC
February 2016

Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group.

Pediatr Blood Cancer 2016 Feb 16;63(2):370-1. Epub 2015 Sep 16.

Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25754DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830388PMC
February 2016

Marketing of personalized cancer care on the web: an analysis of Internet websites.

J Natl Cancer Inst 2015 May 5;107(5). Epub 2015 Mar 5.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (SWG, AC, EB, VV); Harvard Medical School, Boston, MA (SWG, NL, KAJ); Department of Medicine, Brigham and Women's Hospital, Boston, MA (SWG, NL); Harvard School of Public Health, Boston, MA (VV); Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA (KAJ); Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA (KAJ).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822521PMC
May 2015

A summary of the osteosarcoma banking efforts: a report from the Children's Oncology Group and the QuadW Foundation.

Pediatr Blood Cancer 2015 Mar 8;62(3):450-5. Epub 2014 Dec 8.

Children's Cancer and Blood Disorders Program, Randall Children's Hospital, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25346DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304398PMC
March 2015

HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study.

Pediatr Blood Cancer 2014 Sep 22;61(9):1558-64. Epub 2014 Apr 22.

Department of Pediatrics, The Children's Hospital at Montefiore and the Albert Einstein College of Medicine, Bronx, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288578PMC
September 2014

Future of clinical genomics in pediatric oncology.

J Clin Oncol 2013 May 15;31(15):1893-903. Epub 2013 Apr 15.

Dana-Farber Children's Hospital Cancer Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.46.8470DOI Listing
May 2013

Children's Oncology Group's 2013 blueprint for research: bone tumors.

Pediatr Blood Cancer 2013 Jun 19;60(6):1009-15. Epub 2012 Dec 19.

The Department of Pediatrics and Molecular Pharmacology, The Albert Einstein College of Medicine of Yeshiva University, Bronx, NY 10467, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24429DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610028PMC
June 2013

New strategies in sarcoma therapy: linking biology and novel agents.

Clin Cancer Res 2012 Nov 28;18(21):5837-44. Epub 2012 Aug 28.

Deparment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-0875DOI Listing
November 2012

Treatment guidelines for gastrointestinal stromal tumors in children and young adults.

J Pediatr Hematol Oncol 2012 May;34 Suppl 2:S69-72

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0b013e31824e3899DOI Listing
May 2012

Cardiac paraganglioma in an adolescent.

Circulation 2012 Feb;125(5):e322-4

Children's Hospital Boston, 300 Longwood Ave, Boston, MA 02115.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.111.043968DOI Listing
February 2012

Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group.

Cancer 2012 Sep 17;118(18):4597-605. Epub 2012 Jan 17.

Department of Pediatric Hematology-Oncology, Dana-Farber/Children's Hospital Cancer Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27414DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008337PMC
September 2012

Pediatric gastrointestinal stromal tumor.

Semin Pediatr Surg 2012 Feb;21(1):31-43

Department of Pediatric Oncology, Dana Farber Cancer Institute-Children's Hospital Boston, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.sempedsurg.2011.10.003DOI Listing
February 2012

Special considerations in pediatric gastrointestinal tumors.

J Surg Oncol 2011 Dec;104(8):928-32

St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.21868DOI Listing
December 2011

Modeling human osteosarcoma in the mouse: From bedside to bench.

Bone 2010 Nov 6;47(5):859-65. Epub 2010 Aug 6.

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Children's Hospital Boston, Harvard Medical School, 44 Binney St, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2010.07.028DOI Listing
November 2010

Pediatric and wild-type gastrointestinal stromal tumor: new therapeutic approaches.

Curr Opin Oncol 2010 Jul;22(4):347-50

Pediatric Oncology Branch National Cancer Institute National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e32833aaae7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949288PMC
July 2010

Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects.

Lancet Oncol 2010 Jul 27;11(7):670-8. Epub 2010 Mar 27.

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Children's Hospital Boston, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S147020451070062
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(10)70062-0DOI Listing
July 2010

Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without IGF1R genomic amplification.

Int J Cancer 2010 Dec;127(11):2718-22

Department of Pediatric Hematology-Oncology, Dana Farber Cancer Institute and Children's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.25247DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947557PMC
December 2010

Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib.

Pediatr Blood Cancer 2009 Jul;52(7):767-71

Pediatric Oncology, Dana-Farber Cancer Institute and Department of Medicine, Children's Hospital Boston, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21909DOI Listing
July 2009

Pediatric gastrointestinal stromal tumors.

Hematol Oncol Clin North Am 2009 Feb;23(1):15-34, vii

Department of Pediatrics, Texas Children's Cancer Center, 6621 Fannin Street, CC1510.00, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2008.11.005DOI Listing
February 2009